Next Article in Journal
Examining the Association and Directionality between Mental Health Disorders and Substance Use among Adolescents and Young Adults in the U.S. and Canada—A Systematic Review and Meta-Analysis
Previous Article in Journal
Tarsal Tunnel Mechanosensitivity Is Increased in Patients with Asthma: A Case-Control Study
Article Menu
Issue 12 (December) cover image

Export Article

Open AccessArticle
J. Clin. Med. 2018, 7(12), 542; https://doi.org/10.3390/jcm7120542

Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials

1
Department of Medical, Oral and Biotechnological Sciences and CeSI-MeT, G. D’Annunzio University, 66100 Chieti, Italy
2
Department of Bio-Statistics, RCCS Regina Elena National Cancer Institute, 00144 Rome, Italy
3
Division of Medical Oncology 2, IRCCS Regina Elena National Cancer Institute, 00144 Rome, Italy
4
Medical Oncology, Sandro Pertini Hospital, 00157 Rome, Italy
5
Scientific Direction, Regina Elena National Cancer Institute, 00144 Rome, Italy
6
Oncology Unit, Department of Clinical and Molecular Medicine, Medical Oncology, Sapienza University, 00185 Rome, Italy
7
Digital library, Knowledge Center “Riccardo Maceratini” and Patient Library, Regina Elena National Cancer Institute, 00144 Rome, Italy
*
Author to whom correspondence should be addressed.
Received: 15 November 2018 / Revised: 30 November 2018 / Accepted: 8 December 2018 / Published: 12 December 2018
(This article belongs to the Section Oncology)
Full-Text   |   PDF [2188 KB, uploaded 13 December 2018]   |  

Abstract

Evidence has recently emerged on the influence of gender on the immune system. In this systematic review and meta-analysis of phase III randomized clinical trials (RCTs), we explored the impact of gender on survival in patients with advanced cancer treated with immune checkpoint inhibitors (ICIs). We performed a comprehensive search of the literature updated to April 2018, including the Cochrane Central Register of Controlled Trials, PubMed, and EMBASE. We extracted data on study characteristics and risk of bias in duplicate. Of 423 unique citations, 21 RCTs were included, inherently to 12,635 patients. Both males and females showed reduced risk of death associated with ICIs use (HR 0.73, p < 0.001 and HR 0.77, p < 0.001, respectively). Subgroup analyses by specific ICI showed similar OS in both genders for anti-PD-1/PDL-1. Anti-CTLA-4 use was associated with longer OS in men only (HR 0.77, p < 0.012), with the exception of melanoma (in women, HR 0.80, p = 0.006). PFS was longer in men than in women (HR 0.67, p < 0.001 and HR 0.77, p = 0.100, respectively). Conclusively, ICIs use was associated with more favorable outcomes in men, particularly for anti-CTLA-4 agents. In melanoma, not gender-related factors may influence the anti-tumor immune response evoked by ICIs. View Full-Text
Keywords: immune checkpoint inhibitors; anti-PD-1/PDL-1; anti-CTLA-4; gender; sex; nivolumab; pembrolizumab; atezolizumab; ipilimumab; durvalumab immune checkpoint inhibitors; anti-PD-1/PDL-1; anti-CTLA-4; gender; sex; nivolumab; pembrolizumab; atezolizumab; ipilimumab; durvalumab
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).

Supplementary material

SciFeed

Share & Cite This Article

MDPI and ACS Style

Grassadonia, A.; Sperduti, I.; Vici, P.; Iezzi, L.; Brocco, D.; Gamucci, T.; Pizzuti, L.; Maugeri-Saccà, M.; Marchetti, P.; Cognetti, G.; De Tursi, M.; Natoli, C.; Barba, M.; Tinari, N. Effect of Gender on the Outcome of Patients Receiving Immune Checkpoint Inhibitors for Advanced Cancer: A Systematic Review and Meta-Analysis of Phase III Randomized Clinical Trials. J. Clin. Med. 2018, 7, 542.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
J. Clin. Med. EISSN 2077-0383 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top